These benefits, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of focusing on ACKR3 as a singular solution to modulate the opioid technique, which could open new therapeutic avenues for opioid-connected Conditions.These outcomes propose that con